Information Provided By:
Fly News Breaks for June 15, 2015
RDHL
Jun 15, 2015 | 12:28 EDT
Roth Capital raised Buy rated RedHill Biopharma's price target to $30 from $27.50 on positive top line data for RHB-105 to treat H. pylori.
News For RDHL From the Last 2 Days
There are no results for your query RDHL